Open House Originale Rabattverträge 2024-08 - Fluticason/vilanterol (wirkstoffkombination)

Health, Health, Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 30, 2026
Response Due
Active
Status

Opportunity Overview

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-08 - Fluticason/Vilanterol (Wirkstoffkombination)

This is one of 1,754 active Germany Health Services opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth, Health, Health
CountryGermany
CategoryHealth Services
PublishedJuly 31, 2024
Procurement stageActive solicitation
Response dueSeptember 30, 2026
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Germany

Germany – Sickness benefits – Bes. Vers. nach § 140a SGB V zur bildgest. Schmerztherapie im Wirbelsäulenbereich (OH-02/VE/2025)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tralokinumab, ATC D11AH07 für die Zeit 01.08.2025 - 31.07.2027
Germany – Pharmaceutical products – Arzneimittel mit der Wirkstoffkombination Betamethason und Fusidinsäure (ATC: D07CC01)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Prednison (ATC: H02AB07)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Infliximab zur intravenösen Applikation
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Umeclidiniumbromid, ATC R03BB07
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Ebastin (ATC: R06AX22)
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Valproinsäure (N03AG01).

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.